Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8<sup>+</sup> T cell activity and Fcγ receptor-mediated modulation of the tumor microenvironment
Crossref DOI link: https://doi.org/10.1136/jitc-2024-010728
Published Online: 2025-02-25
Published Print: 2025-02
Update policy: https://doi.org/10.1136/crossmarkpolicy
Son, Wonjun
Lee, Yangsoon
Park, Yelim
Park, Kyeong-Su
Kim, Sora
Youn, Hyunseong
Seo, Arim
Sung, Byungje
Lee, Sang Hoon
Won, Jonghwa https://orcid.org/0000-0003-2853-8948
Funding for this research was provided by:
ABL Bio Inc, Republic of Korea (N/A)
License valid from 2025-02-25